Header cover image

Danish Pharmaceuticals & Biotech Stable Growth Stocks

Results

2

0 new

2 companies

ALK-Abelló

Market Cap: DKK 59.9b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.

ALK B

DKK 270.40

7D

1.6%

1Y

45.8%

Novo Nordisk

Market Cap: DKK 1.3t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

NOVO B

DKK 287.25

7D

1.2%

1Y

-44.4%